At its March meeting, EMA’s Committee for Herbal Medicinal Products (HMPC) elected Dr Emiel van Galen as its chair, for a three-year mandate.
Dr van Galen is the Head of Department for Botanicals and Novel Foods at the Medicines Evaluation Board (CBG-MEB) in Utrecht, the Netherlands. He served as vice-chair of the HMPC from January 2017 to January 2020 and has been a member of the Committee since 2004.
From 16 December 2019, edible cannabis products are permitted to be sold in Canada. These must comply with new regulations for edible, inhalable and topical products, designed to reduce the risk of accidental consumption or overconsumption. Edible products are not individually approved for sale, but the regulations instruct manufacturers to provide Health Canada with a written notice of the product – including class of product, description and expected date of offering for sale – then wait 60 days before sale, to give the authorities time to raise any concerns. As the new regulations came into force on 17 October 2019, the earliest date for the sale of edible cannabis products was therefore 16 December 2019. Herbal cannabis products and cannabis oils have been on sale in licensed shops in Canada since 17 October 2018.
By European Coalition on Homeopathic & Anthroposophic Medicinal Products
ECHAMP’s report, ‘Homeopathic and Anthroposophic Medicinal Products in the EU – Spotlight on an Industry’ is now available on the ECHAMP website, presenting a comprehensive review of the sector.
By European Coalition on Homeopathic & Anthroposophic Medicinal Products.